These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29877881)

  • 21.
    Shah R; Sehemby M; Garg R; Purandare N; Hira P; Mahajan A; Lele V; Malhotra G; Verma P; Rojekar A; Dalvi A; Uchino S; Rastogi S; Lila A; Patil V; Shah N; Bandgar T
    Clin Endocrinol (Oxf); 2022 Feb; 96(2):190-199. PubMed ID: 34498757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
    Wild D; Antwi K; Fani M; Christ ER
    J Nucl Med; 2021 Jul; 62(Suppl 2):44S-50S. PubMed ID: 34230073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatostatin receptor based PET/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma.
    Sharma P; Arora S; Karunanithi S; Khadgawat R; Durgapal P; Sharma R; Kandasamy D; Bal C; Kumar R
    Q J Nucl Med Mol Imaging; 2016 Mar; 60(1):69-76. PubMed ID: 24740163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study.
    Antwi K; Fani M; Heye T; Nicolas G; Rottenburger C; Kaul F; Merkle E; Zech CJ; Boll D; Vogt DR; Gloor B; Christ E; Wild D
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2318-2327. PubMed ID: 30054698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 99mTc Labeled Glucagon-Like Peptide-1-Analogue (99mTc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma.
    Sowa-Staszczak A; Trofimiuk-Müldner M; Stefańska A; Tomaszuk M; Buziak-Bereza M; Gilis-Januszewska A; Jabrocka-Hybel A; Głowa B; Małecki M; Bednarczuk T; Kamiński G; Kowalska A; Mikołajczak R; Janota B; Hubalewska-Dydejczyk A
    PLoS One; 2016; 11(8):e0160714. PubMed ID: 27526057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular imaging in the investigation of hypoglycaemic syndromes and their management.
    Pattison DA; Hicks RJ
    Endocr Relat Cancer; 2017 Jun; 24(6):R203-R221. PubMed ID: 28400403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphologically 'invisible' proinsulin - secreting adenoma detected by Ga-68 Exendin-4 (GLP-1 Receptor) positron emission tomography/CT.
    Werner C; Lupp A; Drescher R; Freesmeyer M; Mireskandari M; Stoykow C; Bauschke A; Müller UA
    J Med Imaging Radiat Oncol; 2018 Jun; 62(3):370-374. PubMed ID: 29399966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [
    Otani D; Murakami T; Murakami S; Hanaoka I; Fujimoto H; Shimizu Y; Kawai Miyake K; Sakaki K; Ueda Y; Tanaka D; Ohno T; Shimizu H; Uyama N; Iizuka N; Yabe D; Nakamoto Y; Inagaki N
    Endocr J; 2024 Sep; 71(9):925-933. PubMed ID: 38839345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intermittent disturbances of perception during fasting in a 46-year-old female patient].
    Ravens S; Scheit L
    Internist (Berl); 2020 Sep; 61(9):964-968. PubMed ID: 32734334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.
    Wild D; Béhé M; Wicki A; Storch D; Waser B; Gotthardt M; Keil B; Christofori G; Reubi JC; Mäcke HR
    J Nucl Med; 2006 Dec; 47(12):2025-33. PubMed ID: 17138746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superior Diagnostic Performance of the GLP-1 Receptor Agonist [Lys
    Senica K; Tomazic A; Skvarca A; Kolenc Peitl P; Mikolajczak R; Hubalewska-Dydejczyk A; Lezaic L
    Mol Imaging Biol; 2020 Feb; 22(1):165-172. PubMed ID: 31098984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exendin-4-based imaging in endogenous hyperinsulinemic hypoglycaemia cohort: A tertiary Endocrine centre experience.
    Garg R; Shah R; Tiwari A; Purandare N; Lele VR; Malhotra G; Verma P; Gosavi V; Dalvi A; Kumar Jaiswal S; Patil V; Ramteke-Jadhav S; Lila A; Shah N; Bandgar T
    Clin Endocrinol (Oxf); 2020 Dec; 93(6):678-686. PubMed ID: 32716527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
    Brom M; Oyen WJ; Joosten L; Gotthardt M; Boerman OC
    Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1345-55. PubMed ID: 20111963
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Abdelkawi MM; Romeih MA; Nasr MA; NasrElDin EA
    Eur J Radiol; 2024 Oct; 179():111669. PubMed ID: 39137605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon-like peptide-1 receptor imaging for localization of insulinomas.
    Christ E; Wild D; Forrer F; Brändle M; Sahli R; Clerici T; Gloor B; Martius F; Maecke H; Reubi JC
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4398-405. PubMed ID: 19820010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of (68)Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study.
    Prasad V; Sainz-Esteban A; Arsenic R; Plöckinger U; Denecke T; Pape UF; Pascher A; Kühnen P; Pavel M; Blankenstein O
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1593-600. PubMed ID: 26923247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innovative imaging of insulinoma: the end of sampling? A review.
    Christ E; Antwi K; Fani M; Wild D
    Endocr Relat Cancer; 2020 Apr; 27(4):R79-R92. PubMed ID: 31951592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDOPA PET/CT imaging of insulinoma revisited.
    Imperiale A; Sebag F; Vix M; Castinetti F; Kessler L; Moreau F; Bachellier P; Guillet B; Namer IJ; Mundler O; Taïeb D
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):409-18. PubMed ID: 25367749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 68Ga-NOTA-Exendin-4 PET/CT in Localization of an Occult Insulinoma and Appearance of Coexisting Esophageal Carcinoma.
    Luo Y; Li N; Kiesewetter DO; Chen X; Li F
    Clin Nucl Med; 2016 Apr; 41(4):341-3. PubMed ID: 26647001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-radiolabeled GLP-1 analog exendin-4 for PET/CT imaging of insulinoma in small animals.
    Wu H; Liang S; Liu S; Pan Y; Cheng D; Zhang Y
    Nucl Med Commun; 2013 Jul; 34(7):701-8. PubMed ID: 23652208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.